OMEGA DIAGNOSTICS GR

ODX

Delayed - 01/15 11:35:03 am
57GBX	+0.89%

Turn to zoom

Prev.	56.5000
Open	57.0000
High	59.0000
Low	53.5000
Volume	2 709 541

11/30	Omega Diagnostics Gains 9% on Smaller Fiscal H1 Loss
11/17	Omega Diagnostics' Partner Abingdon Health Granted US FDA Approval to...
11/17	Market Chatter: Abingdon Health Plans $26 Million London IPO
11/12	Omega Diagnostics Rejects Media Report on Rapid Test Performance as Shares...

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bearish	Bullish
Resistance	67,0	76,5	107
Spread/Res.	-15%	-25%	-47%
Spread/Supp.	23%	23%	117%
Support	46,5	46,5	26,3

Sales 2021	12,6 M 17,1 M 17,1 M
Net income 2021	0,50 M 0,68 M 0,68 M
Net cash 2021	7,10 M 9,65 M 9,65 M
P/E ratio 2021	190x
Yield 2021	-

Capitalization	103 M 139 M 139 M
EV / Sales 2021	7,58x
EV / Sales 2022
Nbr of Employees	152
Free-Float	86,4%

Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease,...

>> Read more

Sector :

Diagnostic & Testing Substances

Calendar :

2021-06-30 Earnings Release

Mean consensus	-
Number of Analysts	1
Average target price
Last Close Price	0,57
Spread / Highest target	-
Spread / Average Target	-
Spread / Lowest Target	-